Table 4.
Comparison of corrected values and true values of some test items ( ± s).
| Indicators | Non-inactivated group 2 | After correction for inactivation group 2 | Bias (%) | t-value | P-value |
|---|---|---|---|---|---|
| (n = 30) | (n = 30) | ||||
| TSH (mIU/L) | 7.94 ± 1.03 | 7.95 ± 1.05 | 0.26 ± 0.14 | 0.473 | 0.625 |
| T3 (nmol/L) | 1.11 ± 0.16 | 0.95 ± 0.18 | −0.72 ± 0.43 | 0.639 | 0.421 |
| FT4 (pmol/L) | 18.08 ± 8.64 | 18.09 ± 8.67 | 0.17 ± 0.09 | 0.512 | 0.583 |
| FT3 (pmol/L) | 5.27 ± 3.49 | 5.32 ± 3.54 | 0.54 ± 0.12 | 0.612 | 0.437 |
| CYFRA211 (ng/ml) | 5.28 ± 3.27 | 5.38 ± 1.84 | 0.19 ± 0.40 | 0.197 | 0.846 |
| IRI (mU/L) | 93.47 ± 88.13 | 86.28 ± 80.75 | 0.29 ± 0.80 | 1.006 | 0.327 |
| IL-1β (pg/ml) | 17.26 ± 12.59 | 16.91 ± 10.06 | 0.08 ± 0.45 | 0.376 | 0.709 |
| IL-6 (pg/ml) | 38.45 ± 40.72 | 35.98 ± 35.15 | 0.27 ± 0.53 | 0.572 | 0.522 |
| IL-8 (pg/ml) | 57.52 ± 74.53 | 57.51 ± 73.91 | 0.09 ± 0.22 | 0.003 | 0.997 |
| IL-2R (U/ml) | 820.50 ± 505.187 | 820.67 ± 464.52 | 0.13 ± 0.40 | 0.005 | 0.996 |